Creative Planning’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$672K Buy
52,410
+12,617
+32% +$161K ﹤0.01% 2789
2025
Q4
$358K Buy
39,793
+4,060
+11% +$55.9K ﹤0.01% 3119
2025
Q3
$617K Buy
35,733
+2,631
+8% +$32.4K ﹤0.01% 2547
2025
Q2
$310K Buy
33,102
+3,795
+13% +$31.2K ﹤0.01% 2870
2025
Q1
$208K Buy
29,307
+8,144
+38% +$82.3K ﹤0.01% 3035
2024
Q4
$247K Buy
21,163
+8,618
+69% +$134K ﹤0.01% 2821
2024
Q3
$258K Buy
12,545
+211
+2% +$4.87K ﹤0.01% 2649
2024
Q2
$276K Sell
12,334
-5,094
-29% -$121K ﹤0.01% 2422
2024
Q1
$479K Buy
17,428
+8,456
+94% +$235K ﹤0.01% 1880
2023
Q4
$274K Buy
8,972
+8,757
+4,073% +$252K ﹤0.01% 2154
2023
Q3
$6.8K Buy
+215
New +$8.34K ﹤0.01% 2687
2022
Q2
Sell
-215
Closed -$16K 2452
2022
Q1
$16K Buy
+215
New +$18.2K ﹤0.01% 2161
2021
Q4
Sell
-1,810
Closed -$243K 2176
2021
Q3
$243K Buy
+1,810
New +$274K ﹤0.01% 1729
2020
Q2
Sell
-63,561
Closed -$777K 2093
2020
Q1
$777K Sell
63,561
-20,353
-24% -$274K ﹤0.01% 742
2019
Q4
$1.23M Buy
83,914
+401
+0.5% +$5.58K ﹤0.01% 700
2019
Q3
$1.11M Sell
83,513
-610
-0.7% -$9.73K ﹤0.01% 703
2019
Q2
$1.38M Buy
84,123
+6,100
+8% +$95.9K ﹤0.01% 626
2019
Q1
$1.33M Buy
78,023
+491
+0.6% +$7.32K ﹤0.01% 618
2018
Q4
$1.06M Sell
77,532
-359
-0.5% -$6.67K ﹤0.01% 646
2018
Q3
$2.23M Sell
77,891
-469
-0.6% -$13.6K 0.01% 456
2018
Q2
$2.14M Buy
78,360
+29,430
+60% +$713K 0.01% 452
2018
Q1
$1.03M Buy
48,930
+480
+1% +$11.8K ﹤0.01% 720
2017
Q4
$931K Buy
48,450
+37,035
+324% +$855K ﹤0.01% 774
2017
Q3
$284K Buy
11,415
+8,415
+281% +$159K ﹤0.01% 1361
2017
Q2
$48K Hold
3,000
﹤0.01% 2540
2017
Q1
$42K Buy
+3,000
New +$40.3K ﹤0.01% 2607

Other funds holding NTLA